Onego Bio: Funding, Investors & Team (Sep 2026)
Onego Bio is a company based in the US and Finland that is transforming the food industry by utilizing precision fermentation to create animal-free egg protein. Their product, Bioalbumen, is a sustainable protein option that matches the taste and nutritional value of real eggs, while also offering superior functional properties and a significantly smaller environmental impact. Onego's innovative technology is in high demand in the food industry, and has received recognition for its groundbreaking contributions, including winning Fast Company's 2023 World Changing Ideas awards. Furthermore, Onego is a founding member of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.
Onego Bio has raised $29.0M across 1 funding round on record, the most recent a Series A of $29.0M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Onego Bio Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Onego Bio Funding Rounds
Onego Bio Founders and Leadership Team
Contact details for the Onego Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Onego Bio Funding Compared to Other Biotechnology Startups
Onego Bio's latest round of $29.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Onego Bio in Biotechnology and Helsinki
Companies Similar to Onego Bio
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to…
Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to…
Bioretec Ltd. is a Finnish material technology company focused on the development, manufacturing and…
NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient…
They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’…
StemSight is a startup focusing on cell therapy in Tampere, Finland, where they are working on innovative…
Herantis Pharma is a company focused on addressing medical needs that have not been met by current treatments.
Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and…
Eevia Health is a Nordic life science company based in Finland and Norway, with headquarters in Seinäjoki and…
Nexstim is a medical device company focused on image-guided transcranial magnetic stimulation, dedicated to…
Enifer is a company that specializes in using fungal fermentation to create products from byproducts of the…
Onego Bio Funding FAQs
What does Onego Bio do?
Onego Bio is a company based in the US and Finland that is transforming the food industry by utilizing precision fermentation to create animal-free egg protein. Their product, Bioalbumen, is a sustainable protein option that matches the taste and nutritional value of real eggs, while also offering superior functional properties and a significantly smaller environmental impact. Onego's innovative technology is in high demand in the food industry, and has received recognition for its groundbreaking contributions, including winning Fast Company's 2023 World Changing Ideas awards. Furthermore, Onego is a founding member of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.
How much funding has Onego Bio raised?
Onego Bio has raised $29.0M across 1 round on record. The most recent is a Series A of $29.0M announced in Apr 2024.
When did Onego Bio last raise funding?
Onego Bio's most recent funding round on record is a Series A of $29.0M, announced in Apr 2024.
Who founded Onego Bio?
FundedIQ lists Chris Landowski (Founder) at Onego Bio.
Where is Onego Bio headquartered?
Onego Bio is based in Helsinki, Southern Finland, Finland.
How many employees does Onego Bio have?
Onego Bio is in the 11-50 employee band.
How does Onego Bio's funding compare to other Biotechnology startups?
Onego Bio's latest round of $29.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Onego Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Onego Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.